Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis
2011

Combination Therapy for Choroidal Neovascularization from Toxoplasmosis

Sample size: 1 publication Evidence: low

Author Information

Author(s): Rishi Pukhraj Venkataraman, Anusha Rishi

Primary Institution: Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya

Hypothesis

Can combination photodynamic therapy and bevacizumab effectively treat choroidal neovascularization associated with toxoplasmosis?

Conclusion

Combination therapy with photodynamic therapy and intravitreal bevacizumab is effective in treating choroidal neovascularization secondary to toxoplasma retinochoroiditis.

Supporting Evidence

  • The patient's visual acuity improved from 20/120 to 20/30 after treatment.
  • Choroidal neovascularization regressed at 8 weeks of follow-up.

Takeaway

A 14-year-old girl with vision problems due to an eye infection was treated with two types of medicine, and her vision got much better after a few weeks.

Methodology

The patient underwent verteporfin photodynamic therapy followed by an intravitreal injection of bevacizumab after 2 days.

Limitations

Only one case was reported, limiting the generalizability of the findings.

Participant Demographics

A 14-year-old girl.

Digital Object Identifier (DOI)

10.4103/0301-4738.73728

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication